Jpmorgan Chase & Co »

Adicet Bio shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Adicet Bio (ACET) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Adicet Bio

Tip: Access up to 7 years of quarterly data

All positions including Adicet Bio held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adicet Bio by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $38k 20k 1.89
2023-09-30 $38k 28k 1.37
2023-06-30 $63k 26k 2.43
2023-03-31 $134k 23k 5.74
2022-12-31 $186k 18k 10.42
2022-06-30 $248k 17k 14.61
2022-03-31 $336k 17k 20.06
2021-12-31 $248k 14k 17.43
2020-12-31 $5.0k 381 13.12
2020-09-30 $0 3 0.00